Home › Funds › Fi3 FINANCIAL ADVISORS, LLC › LRMR

Fi3 FINANCIAL ADVISORS, LLC position in LRMR

Larimar Therapeutics Inc · Health Care

Fi3 FINANCIAL ADVISORS, LLC reported holding 2,915 shares of LRMR (Larimar Therapeutics Inc) in its Q2 2026 13F filing — a position valued at US$1.3M, representing 0.30% of its reported portfolio and ranking #34 among its reported holdings. Fi3 FINANCIAL ADVISORS, LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)2.92K sh
Reported value held$1.26M
Portfolio Weight0.30%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Fi3 FINANCIAL ADVISORS, LLC's LRMR position evolved

Fi3 FINANCIAL ADVISORS, LLC first disclosed a stake in LRMR in Q3 2023 at 25,571 shares (US$101K). The position peaked in Q2 2026 at 2,915 shares, worth US$1.3M. Across 12 filings, Fi3 FINANCIAL ADVISORS, LLC increased the stake 5 time(s), trimmed it 2 time(s) and left it unchanged 4 time(s). The most recent filing (Q2 2026) shows 2,915 shares valued at US$1.3M — a reduction of -26,578 shares quarter over quarter.. Notable position changes include a 90% trim in Q2 2026 (shares rose 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 25.57K $101.00K New
Q4 2023 25.45K $115.79K Hold
Q1 2024 25.45K $197.60K Hold
Q2 2024 20.39K $147.81K Reduce
Q3 2024 20.39K $133.53K Hold
Q4 2024 23.80K $92.10K Add
Q1 2025 23.97K $51.54K Add
Q2 2025 24.17K $69.86K Add
Q3 2025 29.24K $94.44K Add
Q4 2025 29.32K $111.72K Hold
Q1 2026 29.49K $132.72K Add
Q2 2026 2.92K $1.26M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LRMR and 13F data

LRMR (Larimar Therapeutics Inc) is a Health Care company. 26 other funds we track also report a position in LRMR — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$108.6M), Defilade Capital Management, L.P. (US$11.2M), DAFNA Capital Management LLC (US$6.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LRMR

All LRMR fund holders →

FAQ

How long has Fi3 FINANCIAL ADVISORS, LLC held LRMR?

Fi3 FINANCIAL ADVISORS, LLC has disclosed LRMR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Fi3 FINANCIAL ADVISORS, LLC's current position in LRMR?

As of Q2 2026, Fi3 FINANCIAL ADVISORS, LLC holds 2.92K shares of LRMR (Larimar Therapeutics Inc), valued at $1.26M, representing 0.30% of its reported portfolio and ranking #34.

Has Fi3 FINANCIAL ADVISORS, LLC been buying or selling LRMR?

In the latest 13F filing (Q2 2026), Fi3 FINANCIAL ADVISORS, LLC reduced its position in LRMR. The position peaked in Q2 2026 at 2.92K shares.

Which other funds hold LRMR?

Other major institutional holders of LRMR include DEERFIELD MANAGEMENT COMPANY, L.P., Defilade Capital Management, L.P., DAFNA Capital Management LLC, among 26 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.